| Title |
Antipsychotic drug treatment for elderly people with late-onset schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, February 2012
|
| DOI | 10.1002/14651858.cd004162.pub2 |
| Pubmed ID | |
| Authors |
Adib Essali, Ghassan Ali |
| Abstract |
Schizophrenia is usually considered an illness of young adulthood. However, onset after the age of 40 years is reported in 23% of patients hospitalised with schizophrenia. At least 0.1% of the world's elderly population have a diagnosis of late-onset schizophrenia which seems to differ from earlier onset schizophrenia on a variety of counts including response to antipsychotic drugs. |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 38% |
| United States | 1 | 13% |
| India | 1 | 13% |
| Unknown | 3 | 38% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 5 | 63% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 174 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| India | 1 | <1% |
| Unknown | 172 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 26 | 15% |
| Researcher | 22 | 13% |
| Student > Ph. D. Student | 20 | 11% |
| Student > Bachelor | 19 | 11% |
| Student > Postgraduate | 13 | 7% |
| Other | 30 | 17% |
| Unknown | 44 | 25% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 53 | 30% |
| Psychology | 26 | 15% |
| Nursing and Health Professions | 16 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 6 | 3% |
| Neuroscience | 5 | 3% |
| Other | 19 | 11% |
| Unknown | 49 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 August 2018.
All research outputs
#2,234,299
of 22,710,079 outputs
Outputs from Cochrane database of systematic reviews
#4,765
of 12,313 outputs
Outputs of similar age
#18,737
of 250,824 outputs
Outputs of similar age from Cochrane database of systematic reviews
#59
of 217 outputs
Altmetric has tracked 22,710,079 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,313 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,824 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 217 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.